Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma

Authors :: Bringhen, S
D'Agostino, M
De Paoli, L
Montefusco, V
Liberati, AM
Galieni, P
Grammatico, S
Muccio, VE
Esma, F
De Angelis, C
Musto, P
Ballanti, S
Offidani, M
Petrucci, MT
Gaidano, G
Corradini, P
Palumbo, A
Sonneveld, Pieter
Boccadoro, M
Bringhen, S
D'Agostino, M
De Paoli, L
Montefusco, V
Liberati, AM
Galieni, P
Grammatico, S
Muccio, VE
Esma, F
De Angelis, C
Musto, P
Ballanti, S
Offidani, M
Petrucci, MT
Gaidano, G
Corradini, P
Palumbo, A
Sonneveld, Pieter
Boccadoro, M
Source :: Bringhen , S , D'Agostino , M , De Paoli , L , Montefusco , V , Liberati , AM , Galieni , P , Grammatico , S , Muccio , VE , Esma , F , De Angelis , C , Musto , P , Ballanti , S , Offidani , M , Petrucci , MT , Gaidano , G , Corradini , P , Palumbo , A , Sonneveld , P & Boccadoro , M 2018 , ' Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma ' , Leukemia , vol. 32 , no. 4 , pp. 979-985 .
Publication Year :: 2018

Database :: OAIster
Journal :: Bringhen , S , D'Agostino , M , De Paoli , L , Montefusco , V , Liberati , AM , Galieni , P , Grammatico , S , Muccio , VE , Esma , F , De Angelis , C , Musto , P , Ballanti , S , Offidani , M , Petrucci , MT , Gaidano , G , Corradini , P , Palumbo , A , Sonneveld , P & Boccadoro , M 2018 , ' Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma ' , Leukemia , vol. 32 , no. 4 , pp. 979-985 .
Notes :: application/pdf, und
Publication Type :: Electronic Resource
Accession number :: edsoai.on1313623325
Document Type :: Electronic Resource

Tools